Inhibitory Effect of LAMS Against Prostatic Cancer in Tumor-earing Mice
|更新时间:2024-01-04
|
Inhibitory Effect of LAMS Against Prostatic Cancer in Tumor-earing Mice
Chinese Journal of Experimental Traditional Medical FormulaeVol. 17, Issue 17, Pages: 223-225(2011)
作者机构:
作者简介:
基金信息:
DOI:
CLC:
Published:2011
稿件说明:
移动端阅览
ZOU Ming-chang, SHENG Yu-qing, CUI Fei-lun. Inhibitory Effect of LAMS Against Prostatic Cancer in Tumor-earing Mice[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(17): 223-225.
DOI:
ZOU Ming-chang, SHENG Yu-qing, CUI Fei-lun. Inhibitory Effect of LAMS Against Prostatic Cancer in Tumor-earing Mice[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(17): 223-225.DOI:
Inhibitory Effect of LAMS Against Prostatic Cancer in Tumor-earing Mice
Objective: To study the inhibitory effect of LAMS on prostatic cancer growth in tumor-bearing mice. Method: Fourty C57 mice inoculated with RM-1 prostate cancer cells for 7 days were divided into 4 groups according to the tumor size:the model group (NS)
cyclophosphamide (CY) group (20 mg ·kg-1)
LAMS low and high dose groups (50
100 mg ·kg-1)
ig
once daily. After 14 days of treatment
the animals were killed. The subcutaneous sarcoma
thymus and spleen were separated and weighted. Inhibition rate
spleen index and thymus index were then calculated. Result: CY 20 mg ·kg-1 significantly inhibited the growth of tumor
the inhibition rate was 40.3%;LAMS(low and high dose) also showed significant inhibitory effect compared with the model group
the inhibition rates were 25.0% and 33.8%. CY could significantly inhibited the thymus index and spleen index in tumor-bearing mice
however
the effects of LAMS were not significant. Conclusion: LAMS have inhibitory effects on RM-1 in tumor-bearing mice
but do not affect the immune function. Furthermore
LAMS has no side effects on chemotherapy drugs such as CY.